Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 272 entries
View as:

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

Phase: N/A Priority: Normal
NCT ID: NCT00909844 Org: User:
Start: 04/30/08 End: 01/31/16 Due: 01/31/17

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00326469 Org: User:
Start: 05/31/06 End: 11/30/09 Due: 11/30/10

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

Phase: N/A Priority: Normal
NCT ID: NCT05431803 Org: User:
Start: 06/30/22 End: 12/13/24 Due: 12/13/25

Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions

Phase: N/A Priority: Normal
NCT ID: NCT00814346 Org: User:
Start: 10/31/08 End: 07/31/12 Due: 07/31/13

Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT02396966 Org: User:
Start: 12/31/14 End: 05/31/18 Due: 05/31/19

Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT00447772 Org: User:
Start: 10/31/04 End: 04/30/08 Due: 04/30/09

Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children

Phase: N/A Priority: Normal
NCT ID: NCT02106351 Org: User:
Start: 04/30/14 End: 09/04/18 Due: 09/04/19

Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis

Phase: N/A Priority: Normal
NCT ID: NCT00447876 Org: User:
Start: 07/31/05 End: 04/30/09 Due: 04/30/10

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT01333397 Org: User:
Start: 03/31/11 End: 09/30/11 Due: 09/30/12

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs

Phase: N/A Priority: Normal
NCT ID: NCT02630654 Org: User:
Start: 03/24/14 End: 11/09/21 Due: 11/09/22

A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01753297 Org: User:
Start: 12/11/12 End: 09/09/19 Due: 09/09/20

Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT00234546 Org: User:
Start: 02/28/03 End: 10/31/07 Due: 10/31/08

A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04083235 Org: User:
Start: 02/11/20 End: 02/18/25 Due: 02/18/26

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT03442725 Org: User:
Start: 02/09/18 End: 05/13/18 Due: 05/13/19

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT04593420 Org: User:
Start: 11/30/20 End: 12/08/22 Due: 12/08/23

IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

Phase: N/A Priority: Normal
NCT ID: NCT00747604 Org: User:
Start: 06/30/06 End: 05/31/14 Due: 05/31/15

Phase IV-Cervical Dystonia-INTEREST IN CD2

Phase: N/A Priority: Normal
NCT ID: NCT01753349 Org: User:
Start: 12/31/12 End: 09/25/17 Due: 09/25/18

A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT06253897 Org: User:
Start: 05/29/24 End: 12/06/24 Due: 12/06/25

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01313273 Org: User:
Start: 06/30/11 End: 06/30/13 Due: 06/30/14

Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel

Phase: N/A Priority: Normal
NCT ID: NCT03562091 Org: User:
Start: 07/20/18 End: 05/15/20 Due: 05/15/21

A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00276380 Org: User:
Start: 02/28/03 End: 03/31/09 Due: 03/31/10

Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.

Phase: N/A Priority: Normal
NCT ID: NCT04736745 Org: User:
Start: 02/10/21 End: 10/28/22 Due: 10/28/23

A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.

Phase: N/A Priority: Normal
NCT ID: NCT05029622 Org: User:
Start: 08/10/21 End: 02/13/23 Due: 02/13/24

Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02807233 Org: User:
Start: 07/31/16 End: 09/30/17 Due: 09/30/18

BN83495 Phase I in Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01840488 Org: User:
Start: 04/30/07 End: 09/30/10 Due: 09/30/11